AbbVie
ABBV
#33
Rank
โ‚น34.671 T
Marketcap
โ‚น19,602
Share price
-2.23%
Change (1 day)
17.86%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น352.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น625.92 B77.53%
2024 โ‚น352.57 B-40.54%
2023 โ‚น592.99 B-53.62%
2022 โ‚น1.278 T3.76%
2021 โ‚น1.232 T282.25%
2020 โ‚น322.40 B-59.67%
2019 โ‚น799.45 B62.13%
2018 โ‚น493.09 B-32.74%
2017 โ‚น733.13 B-1.99%
2016 โ‚น748.03 B18.65%
2015 โ‚น630.47 B180.5%
2014 โ‚น224.77 B-55.57%
2013 โ‚น505.90 B-6.86%
2012 โ‚น543.18 B56.05%
2011 โ‚น348.06 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น967.01 B 54.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.441 T 290.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น851.64 B 36.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น147.68 B-76.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น929.53 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น885.04 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.338 T 113.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น938.91 B 50.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น60.39 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA